Cardiac Tissue Engineers are driving forward the development of advanced therapies to repair and regenerate heart tissue damaged by injury, disease, or aging. Heart disease, which often results in the death of cardiac cells and the formation of scar tissue, is a leading cause of morbidity and mortality worldwide. These specialists focus on recreating the complex architecture of the heart muscle using cutting-edge techniques such as stem cell-based therapies, 3D bioprinting, and synthetic scaffolds to generate functional cardiac tissue. By engineering heart tissues that mimic the structure and function of the natural myocardium, cardiac tissue engineers aim to restore heart function and improve recovery after heart attacks or heart failure.
Cardiac tissue engineers are also focused on enhancing tissue integration and preventing complications like fibrosis, which can impair heart muscle function. They work on optimizing the delivery of growth factors and genetic modifications to accelerate tissue healing and prevent scar tissue formation. Their efforts extend to creating in vitro models of cardiac disease for drug testing and personalized treatment strategies. By advancing these technologies, cardiac tissue engineers are creating more effective therapies for heart disease, potentially reducing the reliance on heart transplants and significantly enhancing the quality of life for patients with cardiac conditions.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States